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Abstract
Starting from common assumptions, we build a rate equation model for multi-strain dis-
ease dynamics in terms of immune repertoire classes. We then move to a strain-level de-
scription where a low-order closure reminiscent of a pair approximation can be applied. We
characterize the endemic equilibrium of the ensuing model in the absence of mutation and
discuss the presence of degeneracy regarding the prevalence of the different strains. Finally
we study the behavior of the system under the injection of mutant strains.
1 Introduction
Many human pathogens exhibit antigenic diversity, with several strains that elicit different
immune responses coexisting in the population or within individual hosts at a given time,
or replacing one another over time. Infectious diseases of this class still defy effective con-
trol, and improving our understanding of their dynamics is of great practical importance.
Modeling multi-strain infections is in itself a theoretical challenge, because typical compart-
mental models of mathematical epidemiology keep track of the infection histories of the hosts
(Castillo-Chavez et al., 1989; Andreasen et al., 1997). This results in a number of variables
that increases exponentially with the number of strains, making the problem intractable even
for a relatively modest number of strains competing through cross-immunity. Ferguson and
co-workers (Abu-Raddad and Ferguson, 2005a,b; Abu-Raddad et al., 2005) characterized the
symmetric equilibrium of a fixed, arbitrary number of strains with identical epidemiologi-
cal parameters, but it has proven very difficult to go beyond the description of equilibrium
properties in this framework.
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Two strategies have been proposed to reduce the complexity of the problem using reason-
able simplifying assumptions. Gog and co-workers (Gog and Swinton, 2002; Gog and Grenfell,
2002) introduced the idea of a status based approach, where different compartments in the
population are associated with current immunity profiles rather than with the individuals’
infection history. In this approach, each host is either susceptible or immune to any given
strain i (polarized immunity). Partial immunity conferred by infection with another strain
j translates into a fraction of those infected by j becoming immune to i, rather than all the
infected becoming partially immune. They showed that this approach, combined with the
assumption of ’reduced infectivity’, results in a drastic reduction of the number of variables
needed to describe the system. Reduced infectivity means that an immune host exposed to a
given strain will not transmit that strain, but will develop an immune response just as a sus-
ceptible infected with that strain would. By contrast with ’reduced susceptibility’, whereby
immunity prevents infection and there is no change in the host’s immune repertoire, under
reduced infectivity immunity prevents further transmission but does not prevent infection.
While this assumption may be difficult to sustain from the biological point of view, it makes
the scaling of the number of variables of the system with the number of strains linear, instead
of exponential, allowing for the exploration of large sets of competing strains.
The second approach, put forward in (Kryazhimskiy et al., 2007), is also status based. It
takes as dynamic variables the fraction of the population that is immune to and the fraction
that is infected with each strain. The equations that determine the time evolution of the
fraction of immune individuals involve, apart from the cross-immunity properties of the set
of strains, the fraction of the population that is immune to pairs of strains. In order to close
the system, time evolution equations for these must be derived, which in turn involve the
fraction of the population that is immune to strain triplets, and so on. In much the same way
as is usually done for spatially extended systems, this process can be truncated at a given
order via a moment closure, i.e., an ansatz that expresses n-tuplets in terms of the lower order
variables. This elegant idea works without the disputable reduced infectivity assumption. It
allows for the reduction of the number of variables that describe the system, which becomes
polynomial in the number of strains, the actual order depending on the order of the closure.
A benchmark for a successful theoretical model is its ability to reproduce the antigenic drift
and shift typical of influenza A when pathogen mutation is included. Both (Gog and Grenfell,
2002) and (Kryazhimskiy et al., 2007) offer applications to influenza A and show that in strain
spaces of dimension 1 and 2 the models do indeed recover the essential qualitative features
of influenza evolution, namely the steady strain replacement over the years combined with
limited diversity at any given time. In higher dimensional strain spaces, however, extinction
or explosive diversity are the generic outcomes of the simplest models (Girvan et al., 2002;
Tria et al., 2005; Ballesteros et al., 2009; Koelle et al., 2009). Theoretical proposals relying
on specific assumptions regarding strain cross-immunity were shown to generate patterns of
antigenic evolution compatible with influenza A (Ferguson et al., 2003; Koelle et al., 2006,
2009; Bedford et al., 2012). However, their actual implementation as computational models
involves a combination of features and is too complex to provide a generally accepted modeling
framework for multi-strain infection dynamics. Indeed, agent-based simulations give us the
insight of virtual experiments but, even with modern computational facilities, they can be too
time consuming to enable a full exploration of parameter space. Additionally, they are not
amenable to analytic treatment. In recent years, along with other contributions in agent-based
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modeling frameworks (Cobey and Pascual, 2011; Buckee et al., 2011; Zinder et al., 2013), the
effort to deal with multi-strain dynamics in a deterministic setting has been continued (Adams
and Sasaki, 2007, 2009; Minayev and Ferguson, 2009a,b; Koelle et al., 2010; Kucharski and
Gog, 2012).
In this paper we add to this effort, using the approach of (Kryazhimskiy et al., 2007)
as a starting point, so as to avoid the large number of degrees of freedom that comes with
infection-history-based rate equation models. We model each strain as a set of integers that
represent different configurations of the pathogen’s antigenic sites or epitopes and we stipulate
an immune response in the host population with some degree of heterogeneity. Different hosts
may build antibodies to different numbers and different sets of antigenic sites. Together with
the assumption that a single matching antibody provides lifelong immunity to a strain, the
immune response scheme completely determines the cross-immunity structure of the strain
set.
In Section 2 we set up the mathematical model, and in Section 3 we study the endemic
equilibrium, adding to the results of (Abu-Raddad and Ferguson, 2005a,b; Abu-Raddad et al.,
2005). In Section 4 we consider a single founding strain in endemic equilibrium and investi-
gate the possible outcomes, coexistence, substitution or extinction, of an immunity evading
mutation, following the system until a new equilibrium is reached. To deal with extinction
and mutation in a description based on continuous variables that represent population den-
sities, we define a cut-off, the inverse of the effective population size, such that if densities
become lower than this cut-off they are taken to be zero. A related study was presented in
(Adams and Sasaki, 2007, 2009), where the fate of the mutant strain was assessed only from
the initial value of the time derivative of the corresponding density of infected.
2 Model
In this model we assume a simple setup where each viral strain is characterized by a certain
number of epitopes, each of which is in one of a number of possible configurations. All
epitopes have equal roles, and the infectious properties of viral strains are all identical; their
effectiveness at infecting a host is fully determined by the host’s immune history. Upon
infection with a strain, the host will produce a certain number of antibodies, each of which
matches the antigene configuration at a particular epitope. In general, the immune system
builds a polyclonal response upon infection with a strain, that is, it will produce antibodies
that respond to all or a large fraction of the virus’s epitopes. However, there is evidence of
variation in the individual immune responses to identical strains and it has been proposed
that children’s immune system may have a monoclonal response (Nakajima et al., 2000; Sato
et al., 2012), meaning that with each infection a child will build an antibody for only one of
the epitopes. In the proposed framework, we model different responses by a probability that
an individual will produce a certain number of antibodies. With these assumptions in mind,
let us derive the rate equation formulation of the model for multi-strain competition in a well
mixed population.
A given strain is characterized by a set of ne integers in {0, . . . , nc}, each representing a
different configuration of the antigene at a certain epitope. This comprises a total of Ns = n
ne
c
strains. At any particular time, an individual may be infected with at most a single strain;
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they are said to be susceptible if they are not infected with any strain. The assumption of
no co-infections (no infection by more than one strain) is arguable, but can be defended in
two ways: (i) a sick individual tends to stay home, and thus isolate himself from contact with
new infections, and (ii) upon infection the immune system is highly active and responds more
effectively to secondary infections.
Additionally, each individual in the population has an immune history made up of ne sets
of integers, representing antibodies against specific configurations of the antigenes at each
of the ne epitopes. To make the model amenable to the analytical treatment that will be
presented in subsection 2.2, we further assume that having one matching antibody for any
of the epitope configurations is enough to grant total immunity against a strain. In formal
terms, we say an individual with immune history A = {A1, ..., Ane} is immune to a strain
i = {i1, ..., ine} if ∃j : ij ∈ Aj , and in this case we write i ∈ A. Otherwise, we write i /∈ A.
Consider now the formalization of immunity acquisition. Take an individual with immune
history A as discussed above. Upon infection with strain i, the immune repertoire becomes
B = {B1, ..., Bj}, where for each j we have either Bj = Aj , if an antibody was not produced
for epitope j, or Bj = Aj ∪ {ij}, if an antibody was produced for that epitope. For each
infection, consider that the number of antibodies produced follows a distribution p{16α6ne},
where pα represents the probability of α antibodies being produced. Furthermore, consider
that antibodies for each epitope have the same probability of being produced, leaving aside
the possibility of epitope immunodominance (Cobey and Pascual, 2011), which for a given
p{α} would reduce the diversity of immune responses.
Let us now define the processes that describe the dynamics. We assume that the popu-
lation is at demographic equilibrium, that is, the rate of birth of individuals equals the rate
of death. An important assumption made at this point is that all individuals have the same
death rate, meaning we do not consider an age structure or disease-related death. Finally, we
consider a well mixed population, or in other words pairwise interactions occur with the same
probability between any two individuals in appropriate states. Let Ik be the fraction of indi-
viduals infected with strain k and S be the fraction of susceptible (not infected) individuals.
The following processes are then present:
1. Birth-death: At rate µ, each individual becomes na¨ıve (immune repertoire A = ∅)
and susceptible.
2. Infection: At rate βS, each individual infected with strain k tries to infect a susceptible.
The susceptible becomes infected if it is not immune to k. The overall rate of attempted
infection per individual in the population is βIkS.
3. Recovery: At rate γ, each infected individual becomes susceptible. The overall rate
per individual is γI.
4. Acquiring Immunity: Infected individuals are immune to all strains. Upon recovery,
an individual adds α antibodies corresponding to the infecting strain. The number
α > 1 follows the prescribed distribution p{α}. Each possible antibody is produced with
the same probability.
5. Mutation: At rate m, each strain present in the population changes a random antigene
to a random new one, if the infected individual is not immune to the new strain. We
say the old strain mutated to the new one. The overall rate of attempted mutation per
individual is mI.
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2.1 Immune history description
This model is a generalization of the simple classical Susceptible-Infected-Recovered (SIR)
model to a system with multiple circulating strains. To develop equations for our system, we
need to set up classes corresponding to each immune history, representing different immunity
profiles in the population due to contact with different diseases. We also need to specify
how these classes evolve into one another, that is, how immunity is acquired upon infection.
As we will see, this characterizes the cross-immunity profile, that is, the way strains confer
immunity to each other. Finally, we must specify the structure of “strain space” by defining
what strains are allowed to mutate into one another.
Let SA be the fraction of individuals not infected with any strain, generically referred to
as “healthy” or “susceptibles”, with immune history A, and IiA be the fraction of individuals
infected with strain i with immune history A. Let C(A, k,B) denote the probability that upon
infection with strain k the immune history of an individual changes from B to A. Define also
Mi as the mutational neighborhood of i, i.e., the set of strains to which i may mutate (here
corresponding to strains that are related by changing the configuration of a single epitope).
Then the dynamics presented above may be described in a rate equation formalism as:
S˙A = µ (δA,∅ − SA) + γ
∑
k
IkA −
∑
k
(1− δk,A)βIkSA ,
I˙jA =
∑
B
∑
k
C(A, k,B) (1− δj,B)
(
δjkβI
kSB +mjkI
k
B
)
+
− (m+ γ + µ)IjA ,
(1a)
(1b)
where mjk = δj,Mk m/|Mk|. Here and throughout, |.| applied to a set denotes the cardinality,
or number of elements. We use the Kronecker Delta symbol in a generalized manner: if i,j
are both strains, then δij = 1 if i = j, and zero otherwise. Similarly, if A and B are both
immune history sets, δA,B equals one if A = B, and zero otherwise. Finally, if i is a strain and
A is an immune history or mutational neighborhood, δi,A = 1 if i ∈ A, and zero otherwise.
The first set of equations describes the time evolution of the fraction of susceptibles with
immune history A. The first term describes death of susceptibles with any immune history
and birth of na¨ıve (immune history A = ∅) susceptibles. The second term represents the
increase of susceptibles with immune history A due to recovery of individuals infected with
any strain and immune history A. The last term represents the decrease of susceptibles with
immune history A due to infection with each strain k; the δk,A accounts for the fact that
susceptibles immune to k (that is, for which k ∈ A) cannot be infected by strain k.
The second set of equations describes the time evolution of the fraction of individuals
infected with strain j and immune history A. The first term has two components, corre-
sponding to each of the terms in the final parenthesis. The first term in the parenthesis
accounts for infection with strain j of susceptibles with immune history B. The second ac-
counts for mutation of the strain k infecting individuals with immune history B to strain j.
Both these terms are multiplied by C(A, k,B) and summed over all B and k; this accounts
for acquiring of immunity that leads from history B to history A. The Kronecker Delta δjk
is introduced simply for notational compactness and ensures that only strain j contributes
to that term. The 1 − δj,B factor deals with the fact that individuals immune to j cannot
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be infected by that strain, whether through contact or through mutation. Finally, the last
term in this equation accounts for the decrease in individuals infected with strain j due to
mutation, recovery, and natural death.
There are 2Ns(Ns + 1) equations in this description. However, they imply one conserva-
tion condition that arises from demographic equilibrium and says that the total number of
individuals in the population is constant:∑
A
∑
k
IkA +
∑
A
SA = I + S = 1 . (2)
Thus, we have 2Ns(Ns + 1)− 1 independent equations.
2.2 Strain-level description
As mentioned above, this type of rate-equation formalism rapidly leads to a very large number
of equations. This is because we must keep track of all possible immune histories; if there are
Ns strains circulating, there are 2
Ns different immune histories, corresponding to an individual
having or not having an antibody corresponding to each particular epitope configuration.
Correspondingly we find on the order of 2Ns equations, as we saw above. This leads to two
main complications: (i) it is difficult to deal with the enormous number of ensuing equations,
either analytically or even numerically, and (ii) the very large number of different immune
histories in relation to the population size means that we subdivide the population into a large
number of classes which correspondingly have very small numbers of elements. This can make
stochastic effects important, putting into question the deterministic rate equation formalism
for reasonable population sizes. Note that the rate equation formalism implicitly considers
the limit of infinite population sizes by considering fractions of individuals as continuous
variables.
To simplify system (1), we make use of the general strategy outlined in (Kryazhimskiy
et al., 2007) which requires that: (i) immunity is not lost from an infection process, (ii)
each strain confers total immunity to itself, and (iii) acquiring of immunity is independent of
previous history. All these are satisfied by the model described here: (i) is trivial, and (ii)
and (iii) are a consequence of the fact that in this model at least one antibody is produced
upon infection and one antibody is enough to grant immunity. Adapting the technique of
(Kryazhimskiy et al., 2007) to this model, we define the immunity variables:
ξi =
∑
A:i
SA , η
j
i =
∑
A:i
IjA , (3)
where A : i is shorthand for A : i ∈ A. The physical meaning of these variables should be
clear: ξi represents the fraction of healthy individuals immune to strain i, and η
j
i represent
the fraction of infected with strain j that are immune to strain i. Note that, because we
have chosen to account for immunity updating at the time of infection, being infected with
strain i requires being immune to it, and so ηii represents the fraction of individuals infected
with strain i. The idea here is to describe the system in terms of a set of variables that
allows for reasonable approximations. Although it is easier to write the equations for the
system in the form given by (1), taking the point of view of the single strain as opposed
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to generic immune history will lead to natural approximations on the way strains interact
through cross-immunity.
Define Ci(k,B) =
∑
A:iC(A, k,B), the probability of ending up with immunity to strain
i upon infection with strain k. In the model described above we have, for i /∈ B, Ci(k,B) ≡
σik ≡
∑ne
α=1 pασ
(α)
ik , where σ
(α)
ik corresponds to the production of exactly α antibodies, which
happens with probability pα. Simple combinatorial arguments tell us that:
σ
(α)
ik = σ
(α)
ki =
{
1 , |i ∩ k| > ne − α ,
1− (ne−|i∩k|)!(ne−|i∩k|−α)!
(ne−α)!
ne!
, |i ∩ k| ≤ ne − α .
(4)
Here, i∩ k denotes the set of matching antigenes between strains i and k. We find that σik is
independent of previous immune history B. On the other hand, Ci(k,B) = 1 if i ∈ B, that
is, immunity is not lost upon infection. The matrix (σik) is central to the model and encodes
the cross-immunity granted by each strain to every other.
Expressions (4) become particularly simple for α = 1 and for α = ne. For α = 1, (4)
reads:
σ
(1)
ik = σ
(1)
ki =
|i ∩ k|
ne
, (5)
meaning that cross-immunity of two strains is simply given by their fraction of identical
epitopes. For α = ne,
σ
(ne)
ik = σ
(ne)
ki =
{
1 , |i ∩ k| > 0 ,
0 , |i ∩ k| = 0 , (6)
which simply states that each strain confers total cross-immunity to any other strain so long
as it shares at least one antigene with it, and there is no cross-immunity between completely
different strains.
Appropriately summing over immune histories in equations (1), we find:
ξ˙i =
∑
k
[
γηki − βηkk(ξi − ξik)
]
− µξi ,
η˙ji = βη
j
j [ξi − ξij + σij(1− I − ξi − ξj + ξij)] +
+
∑
k
mjk
[
ηki − ηkij + σij(Ik − ηki − ηkj + ηkij)
]
+
− (m+ γ + µ)ηji .
(7a)
(7b)
Here, ξij and η
k
ij are so-called second-order variables and denote fractions of the population
that are immune to i and j simultaneously, while being respectively healthy or infected with
strain k. Note that this description would be exact if we knew the time evolution of these
variables. However, describing their evolution requires introducing further equations, which
will depend on further variables describing simultaneous immunity to higher numbers of mul-
tiple strains. This in turn will require the introduction of equations for higher order terms.
Thus, to make the problem tractable, we must truncate the system at some order by speci-
fying a so-called closure relation, a heuristic description of a higher-order variable describing
simultaneous immunity in terms of lower-order variables. Here we adopt a closure of order
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one, that is, we close the system by providing descriptions for the second order variables.
The main strength of this approach is that it becomes easier to make assumptions based on
physical ideas about the structure of the cross-immunity interactions between strains, leading
to a significant simplification of the original system. We introduce a particular closure below.
With a closure of this order, there are a total of Ns(Ns + 1) equations in this description.
This can still be a large number, but represents a considerable reduction from exponential to
quadratic in the number of strains.
We note that a simple and reasonable closure for ξij is (Kryazhimskiy et al., 2007):
ξij = (1− σij)ξiξj + σijmin(ξi, ξj) . (8)
For each pair i, j of strains, this expression interpolates between the σij = 0 scenario, where
the probability of being immune to i and j are independent, and the σij = 1 scenario, where
infection by i guarantees immunity to j.
In order to bring equations (7) to closed form when m 6= 0, a similar assumption should
be made to express ηkij in terms of η
k
i , η
k
j . However, since we will side step (7) when dealing
with mutations, this additional closure assumption will be left unspecified. The set (7) of
ordinary differential equations (ODEs) with m = 0 together with the closure assumption (8)
describes the behaviour of our model in the absence of mutations and will be called from now
on the ODE model.
3 Endemic equilibrium
Let us now look at the endemic equilibrium of equations (7) in the absence of mutations.
3.1 Deriving an equation for equilibrium
Equations (7b) for i = j, that is, for the total fractions of infected with each strain, tell us
that, for all j:
ηjj [R0(1− I − ξj)− 1] = 0 , (9)
where R0 = β/(γ + µ). Now let Λ = {j : ηjj 6= 0}. Then we have I =
∑
j∈Λ η
j
j , and for all
circulating strains j ∈ Λ we find:
ξj = ξ = 1− I −R−10 . (10)
This shows that the existence of an endemic equilibrium requires R0 > 1, which is directly
analogous to results from classical SIR models. Because all strains in this model are equiv-
alent as they have the same β and γ, the equilibrium also forces all immunity variables ξj
corresponding to the circulating strains to take the same value.
In equilibrium, defining ηi =
∑
j η
j
i , equations (7a) for i ∈ Λ can be written as:
− γηi − β
∑
j∈Λ
ηjjξij + βIξ + µξ = 0 . (11)
Summing over all j in equations (7b) leads to
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ηi = R0
ξI +∑
j∈Λ
ηjj [−ξij + σij(1− I − 2ξ + ξij)]
 . (12)
Substituting this result into eq. (11) and using (10) for I, we find∑
j∈Λ
Cijη
j
j =
µ
γ
ξ(1− ξ) , (13)
where
Cij = ξij
[
σij +
µ
γ
]
+ σij
(
R−10 − ξ
)
. (14)
Equation (13) is a linear system of N˜S equations in N˜S variables, where N˜S = |Λ| is the
number of circulating strains. Because for a given closure ξij = f(ξi, ξj , σij), ξij becomes a
function of ξ and σij for i, j ∈ Λ; the solution of eq. (13) gives the individual prevalences as a
function of ξ, which can in turn be found by substitution into eq. (10). For a certain solution
for the ηjj , the crossed η
j
i can be found through the equilibrium of eq. (7b):
ηji = R0η
j
j [ξi − ξij + σij(1− I − ξi − ξj + ξij)] . (15)
In particular, note that for all i we have j /∈ Λ⇒ ηji = 0.
3.2 Symmetric equilibrium
Let δj ..= η
j
j − I/|Λ|. Note that as a consequence
∑
j∈Λ δj = 0. Substituting into eq. (13), we
find ∑
j∈Λ
Cijδj +
I
|Λ|
∑
j∈Λ
Cij =
µ
γ
ξ(1− ξ) . (16)
For a symmetric equilibrium to exist, (δj)j∈Λ = 0 must be a solution. In that case, we
must have ∑
j∈Λ
Cij =
|Λ|
I
µ
γ
ξ(1− ξ) . (17)
In particular,
∑
j∈ΛCij must be independent of i. Conversely, if
∑
j∈ΛCij is independent
of i then eq. (17) together with eq. (10) become an equation for the total infective density
I whose form will depend on the closure assumption. Given a solution I of this equation,
the individual prevalences are then ηjj = I/|Λ| for all j. Assuming that there is at least one
solution I in the interval (0, 1], we conclude that the system has symmetric equilibria if and
only if
∑
j∈ΛCij is independent of i. Since by construction the lines of (σij) are permutations
of each other (all strains are equivalent), and since we have found that Cij depends on i and j
only through σij , this condition is always fulfilled when Λ coincides with the set of all strains.
Let us then study eq. (17) for the total prevalence in a symmetric equilibrium with all
strains present. Define σ¯ =
∑
i∈Λ σij/|Λ|, for any j. This is well defined because, since the
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lines of the matrix (σij) are permutations of each other, this quantity is independent of j. For
the same reason, we may define the j-independent (equilibrium) quantities s¯ =
∑
i∈Λ ξij/|Λ|
and s˜ =
∑
i∈Λ σijξij/|Λ|. With these definitions, by summing over all i in eq. (13) we obtain
an equation for the total infected density I:
I
[
σ¯
(
R−10 − ξ
)
+
µ
γ
s¯+ s˜
]
=
µ
γ
ξ(1− ξ) , (18)
where ξ, s¯ and s˜ are to be understood as functions of I due to the equilibrium constraints
eq. (10).
To proceed, we must now settle for a specific closure relation. Let us consider the one
defined by eq. (8). Using (10) for ξ, some algebra leads to an explicit cubic equation for I
depending only on system parameters:
P3(I) =R0
[
σ¯(1− σ˜) + µ
γ
(1− σ¯)
]
I3 +
+ (2−R0)
[
σ¯(1− σ˜) + µ
γ
(1− σ¯)
]
I2 +
+
{
σ¯
[
R−10 (1− σ˜) + σ˜
]
+
µ
γ
[
R−10 (1− σ¯) + σ¯
]}
I +
− µ
γ
(
1−R−10
)
= 0 ,
(19)
where σ˜ ..=
∑
i∈|Λ| σ
2
ij /(|Λ|σ¯).
For R0 > 1, eq. (19) always has a solution in (0, 1) which for µ/γ  1 is approximately
given by :
I ≈ µ
γ
R0 − 1
σ¯[1 + σ˜(R0 − 1)] . (20)
This should be compared with I = µγ (R0− 1) for the prevalence of each strain of the classical
SIR model in the same approximation, and shows how strain cross-immunity reduces overall
prevalence.
In general, the polynomial P3 satisfies P3(0) < 0, P3(1) > 0 and so it has either one root
or three roots in (0, 1). For R0 < 2, it is easy to check that there is only one root in (0, 1). For
R0 large enough, however, an additional pair of roots may exist for certain choices of (σij).
These two roots correspond to a stable and an unstable equilibrium for the total density of
infected, and they are ’unphysical’, in the sense that they have no correspondence with the
SIR model and are a consequence of the closure assumption eq. (8). It can be seen that they
are associated with cross immunity profiles which have values of σij well away from the values
0 and 1 for which the closure is exact. Moreover, the mechanism behind the high prevalence
additional equilibrium is as follows: the susceptibility to reinfection is overestimated because
cross-immunity is underestimated, and so infection of individuals who have been infected
previously by other strains is overestimated.
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3.3 Agent-based model
In order to check that this additional stable equilibrium is indeed an artifact of the closure
assumption, we set up a fully stochastic agent-based model that directly implements the
immune-history-based model as described by steps 1-5 of Section 2 (retaining the assumption
that any antibody against a strain confers total immunity). Taking parameter values for which
the ODE model predicted a low prevalence equilibrium with I ≈ 4.3 · 10−4 and ξ ≈ 0.93, and
a high prevalence equilibrium with I ≈ 0.66, ξ ≈ 0.27, we performed simulations from initial
configurations close to each of the predicted equilibria. The implementation of the initial
configuration was made maximally random given those values as follows. First, a fraction
I/Ns of the population was infected with each of the possible strains. We considered a fully
monoclonal population (σij = σ
(1)
ij ), which means that each infected agent carried exactly
one antibody against the infecting strain. Then, we added a random antibody to the immune
history of each agent, with uniform probability for each antibody, until the fraction immune to
one arbitrary strain attained the equilibrium value for ξ. Assignment of a previously existing
antibody was ignored. With this procedure, the resulting immunity to any strain is close to
the equilibrium value.
Simulations started off in this way for the values of I and ξ associated with the high
prevalence equilibrium are shown in Fig. 1, right panel. In contrast, simulations started off
for the low-prevalence values of I and ξ exhibit only fluctuations due to finite size effects, as
one would expect in a stochastic realization of a true mean field equilibrium, see Fig. 1, left
panel.
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Figure 1: Comparison of agent-based simulations with integration of the ODE model for the evolution of the total prevalence with all
strains circulating starting from (left:) initial conditions close to the high prevalence equilibrium, and (right:) initial conditions close
to the low prevalence equilibrium. Parameters are: ne = 3, nc = 2, σij = σ
(1)
ij , R0 = 15, γ = 90 year
−1 and µ = 70 year−1. The
agent-based simulations use 5 · 106 agents and are averaged over 30 runs.
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3.4 Degeneracy of the symmetric equilibrium and coexistence
of non-symmetric equilibria
We will now show how certain cross immunity profiles, which arise under common assump-
tions, can give rise to unexpected properties for the endemic equilibrium of a multi-strain
system.
To see the relation between the properties of the cross-immunity matrix and equilibrium,
assume that a symmetric equilibrium does exist. In particular, as we have just seen, this is
always the case when all strains are circulating. Then, the equilibrium is degenerate if and
only if: ∑
j∈Λ
Cijδj = 0 (21)
admits a nontrivial solution for (δj)j∈Λ such that
∑
j∈Λ δj = 0. Since by hypothesis the
sum
∑
j∈ΛCij must be independent of i and the matrix (Cij) is symmetric, the line sum∑
i∈ΛCij is independent of j, and therefore any nontrivial solution (δj)j∈Λ of equations (21)
fulfills
∑
j∈Λ δj = 0. Since the sum of the components of any eigenvector associated with the
zero eigenvalue of (Cij) is null, any nontrivial element of the kernel of (Cij) corresponds to a
non-symmetric endemic equilibrium.
In general, (Cij) is non-degenerate, but for some particular choices several properties of
the cross-immunity matrix (σij) contrive to produce a (Cij) with a high dimensional kernel,
as we will see shortly.
Consider first the case when all strains are circulating. For most parameter choices, the
matrix (σij) is non-degenerate. However, as discussed in Section 2.2, a simple and natural
choice for modeling cross-immunity is to take σij = σ
(1)
ij , which corresponds to measuring the
cross-immunity between two strains by the number of overlapping antibodies. The resulting
cross-immunity matrices are directly related to the Hamming distance matrix, and this can be
used to compute their spectrum (Gopalapillai, 2009), which turns out to be highly degenerate
and also quite simple: it has a positive (Perron-Frobenius) non-degenerate real eigenvalue,
another positive eigenvalue with multiplicity ne(nc−1), and a zero eigenvalue with multiplicity
nnec −ne(nc− 1)− 1. The matrix (σ2ij) also has a positive (Perron-Frobenius) non-degenerate
real eigenvalue, and, for ne ≥ 3 and nc ≥ ne − 1, analysis of several particular cases reveals
that it is also degenerate, with another two positive eigenvalues of multiplicities ne(nc−1) and
ne(ne− 1)(nc− 1)2/2, and a zero eigenvalue of multiplicity nnec −ne(nc− 1)(1 + (ne− 1)(nc−
1)/2)−1. Also for this particular choice of σij = σ(1)ij , analysis of numerous examples indicates
that the eigenvectors of (σ2ij) are also eigenvectors of (σij) and that, moreover, all eigenvectors
of (σ2ij) associated with the zero eigenvalue are also eigenvectors of (σij) associated with the
same eigenvalue.
With closure assumption (8), this implies the degeneracy of the homogeneous system (21).
Indeed, we can then write Cij = C˜ij + b0 = b2(σ
2
ij) + b1(σij) + b0, where bn, n = 0, 1, 2, are
functions of ξ and of the system’s parameters. Equation (21) is equivalent to
∑Ns
j=1 C˜ijδj = 0
because
∑Ns
j=1 δj = 0. The properties of (σij) and of (σ
2
ij) stated above imply that (C˜ij) is
degenerate with a zero eigenvalue with multiplicity nnec −ne(nc−1)(1+(ne−1)(nc−1)/2)−1.
Therefore the equilibrium value for the overall prevalence I corresponds in the ηjj simplex to
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a hyperplane of equilibria, given by the solution space of eq. (21). The preceding argument
holds only for the trivial distribution p1 = 1, p{26α6ne} = 0, and depends on the closure
assumption (8) and on the presence of all strains.
In Figure 2 we illustrate this degeneracy effect for 8 strains, with ne = 3 and nc = 2. The
plot shows orbits with different initial conditions converging to equilibria where, despite the
symmetry of the system with respect to strain permutation, different strains have different
prevalences. In this case, the dimension of the hyperplane of equilibria is 1. In the presence
of mutations, the system may drift within this hyperplane of equilibria.
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Figure 2: Illustration of the degeneracy of the symmetric equilibrium of the ODE model. The incidence of each strain is shown for
two runs with different initial incidences close to equilibrium. Parameters are ne = 3, nc = 2, σij = σ
(1)
ij , R0 = 5, γ = 90 year
−1 and
µ = 70 year−1. The equilibrium value of I/|Λ| is also shown. It was obtained from eq. (19) and was verified to agree with that found
for both runs.
To illustrate the behavior of the degeneracy of the cross-immunity matrix when an arbi-
trary subset of the possible strains is circulating, Fig. 3 shows a measure of the number of
zero eigenvalues of (σij) and (σ
2
ij) with i, j in each of the possible subsets. For each possi-
ble number of strains Nd considered to not be circulating, let CNd be the set of all possible
combinations of circulating strains. Then the total number of zero eigenvalues for all possible
combinations in CNd is shown normalized by |CNd |. Three simple choices of cross-immunity
profiles are shown for different choices of ne and nc. We see that degeneracy is overall rare,
although it is particularly high for the σ
(1)
ij case mentioned above when most strains are
circulating.
Closures involving higher powers of σij will typically lift the degeneracy. Writing ξij as a
Taylor expansion in powers of σij , we have, in equilibrium:
ξij =
N∑
n=0
an(ξ)σ
n
ij . (22)
The highest power N can in principle be infinity, but is typically small. Substituting in the
definition of Cij we have:
Cij =
N+1∑
n=0
bn(ξ)σ
n
ij , (23)
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Figure 3: Illustration of the degeneracy of (σij) (dots) and (σ
2
ij) (squares) for σij = ασ
(1)
ij + (1− α)σ(ne)ij , for different values of α and
two choices of ne and nc. (see main text for details). (left): ne = 2, nc = 4. (right): ne = nc = 3.
where:
bn(ξ) = an−1(ξ) +
µ
γ
an(ξ) + δn1(R
−1
0 − ξ) , (24)
with the convention that aN+1 = a−1 = 0. Using eq. (21), we find the condition for equilib-
rium:
N+1∑
n=1
bn(ξ)
∑
j∈Λ
σnijδj = 0 , (25)
where again we have used the fact that
∑
j∈Λ δj = 0 to drop the zeroth-power terms. The
properties that relate the spectra and eigenspaces of (σ2ij) and (σij) for σij = σ
(1)
ij do not seem
to carry over to higher powers, and so for N > 2 the system (25) becomes non-degenerate
even for the simplest cross-immunity profile σ
(1)
ij .
A common approach in the literature is to study the properties of equilibrium for simple
models such as the one presented here (Abu-Raddad and Ferguson, 2005a,b; Abu-Raddad
et al., 2005; Cobey and Pascual, 2011), and the particular cross-immunity profile associated
with degeneracy is often chosen (Zinder et al., 2013). As such, we believe it is important
to keep in mind that simple models with reasonable assumptions may lead to the presence
of degeneracy; this degeneracy should be treated as unphysical, since, as can be seen from
the discussion presented here, assuming other forms of cross-immunity, or most importantly
increasing the order of the closure or assuming not all possible strains are circulating, will in
general lift the degeneracy.
4 Injection of mutant strains
In this section we explore the behavior of our multi-strain model from an evolutionary per-
spective. Instead of assuming the presence of a certain number of coexisting strains, as one
is lead to by the analysis of the equilibria of eq. (7) in the absence of mutations, we shall
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investigate how diversity may develop from a single founding strain. We consider eq. (7) for
two strains, the founding strain 1 and strain 2 in its mutational neighborhood. We also in-
voke the closure assumption (8). For a particular choice of the distribution pα, α = 1, ..., ne,
we assume this system to be in equilibrium with strain 2 absent, with the corresponding
single strain equilibrium values ξi and η
j
i , i, j = 1, 2, when a mutation occurs. To represent
a mutation event in the ODEs framework we use, we introduce an implicit population size
N and use the initial conditions η11(0) = η
1
1 − 1/N , η22(0) = η21(0) = 1/N , with the remaining
variables unchanged at their single strain equilibrium values.
In contrast with other models where invasion of escape mutants may be conditioned,
mutant strain 2 is always a successful invader. It will always undergo a period of exponential
growth, because immunity in the population is below its equilibrium value. More precisely,
it can be seen from eq. (7) that the initial rate of this exponential growth of η22(τ), in terms
of nondimensional time τ = t/(γ + µ), is g = R0(ξ1
γ+µ
γ − ξ2 − η11) ≈ R0(ξ1 − ξ2), where the
approximation holds for µ  γ. This growth factor is always positive. In Fig. 4 we show a
plot of g as a function of R0 and the single non trivial cross-immunity parameter σ using the
approximation:
g(R0, σ) = (1− σ)(R0 − 1) σ(R0 − 1) +R0
σ(1− σ)(R0 − 1) +R0 , (26)
which holds for µ γ.
Figure 4: Plot of the approximate initial growth factor g of the invading strain as a function of σ and R0.
We are interested in monitoring the behavior of the system beyond this initial phase of
exponential growth, and check if any of the variables η11, η
2
2 ever goes below 1/N , the value
that corresponds to a single individual in a population of size N and therefore to extinction
of the corresponding strain.
Even for a population size as large as 108, the most common outcome of mutation im-
plemented in this way is extinction of the founding strain, followed by extinction of strain 2.
The reservoir of susceptibility to strain 2 in the initial population fuels a huge epidemic of
2, causing first the extinction of strain 1 and then that of strain 2 because of a depletion of
susceptibles, whose time scale for reposition is much slower.
This phenomenon is determined mainly by the rate g. Different outcomes can be engi-
neered by fine-tuning parameter g through the choice either of R0 or σ. For small values of
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g, corresponding to R0 close to one or to almost total cross-immunity, we may observe strain
substitution, or even strain coexistence, after mutation (see Fig. 5). However, for these val-
ues of g invasion by strain 2 becomes so slow that stochastic extinction events prevent these
outcomes from being observed in agent-based simulations and most likely in real systems.
Note that relaxing the assumption that the original strain has reached equilibrium when
the mutant is injected further favors extinction. A more detailed discussion of the implications
of these results is presented in Section 5.
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Figure 5: lllustration of the different possible outcomes of an invading mutation occurring at the single strain equilibrium, as a function
of the initial growth factor g of the invading strain, for different values of α. Note the qualitatively similar behavior regardless of the
value of α, whose specific value appears only to set the precise transition value of g between different outcomes. Here, population size
is 108.
5 Discussion and Conclusions
This work deals with multi-strain systems competing through cross-immunity in an SIR type
framework with vital dynamics. Each strain is characterized by a particular configuration,
out of nc possibilities, of each of its ne epitopes, and all Ns = n
ne
c strains have the same
epidemiological parameters. The immune response of the population is heterogeneous, in the
sense that the number of epitopes to which antibodies are produced upon infection may vary
in the population. It is homogeneous in the sense that any immune repertoire with at least
one matching antibody confers full protection against a challenging strain.
In the spirit of (Kryazhimskiy et al., 2007), we built a reduced deterministic model via
a closure assumption that postulates the form of strain immunity cross-correlations. For
this reduced model, we studied the properties of the endemic equilibrium in the presence
of the whole set of strains and of arbitrary subsets of this set. We obtain two results that
highlight a word of caution against possible unphysical consequences of seemingly reasonable
assumptions made in the scope of analytic models.
First, we find, in a region of parameter space, a high prevalence endemic equilibrium in
addition to the SIR low prevalence equilibrium. Comparison with agent-based simulations
show that this additional equilibrium is an artifact of the closure assumption. Second, we
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obtain conditions for the endemic equilibrium to be symmetric, reflecting the symmetry of
the full system with regard to strain permutation. We then find that for a particular choice
of the immune response profile of the population this symmetry is broken, and there exists a
manifold of non-symmetric endemic equilibria.
The main goal is to explore the consequences of the basic assumptions made about the
cross-immunity competition mechanisms in the presence of mutations. In particular, we
investigated if the former are compatible with the build up of antigenic diversity from a single
founding strain. Although the reduced deterministic model developed here may include the
representation of mutations, it is well known this treatment of discrete mutation events is
too unrealistic. Here we adopted a mixed approach in which a cut-off value for the fraction
of the population in each class stands for an implicit population size, and mutations are
implemented by an instantaneous change in the values of these variables translating the
switch of an individual infected with a given strain to an individual infected with a mutant.
Extensive numerical integrations of the model show that, except in a small region of pa-
rameter space that allows strain substitution or strain coexistence starting from a founding
strain, a mutation event leads to disease extinction. These results are confirmed by agent-
based simulations, which show furthermore that, due to stochastic extinctions, the regimes
of strain substitution and addition are not observed in reasonably sized populations. This
is in contrast with the development of limited and even explosive diversity reported in the
literature for similar models (Ferguson et al., 2003; Koelle et al., 2006; Minayev and Ferguson,
2009a,b). The motivation for these models is to find the conditions that reproduce the char-
acteristic phylogenetic pattern of influenza A, and extinctions are avoided either by working
with continuous density variables and very low, perhaps unphysical, cut-offs (Minayev and
Ferguson, 2009a,b), or by including immigration of infectives (Ferguson et al., 2003; Koelle
et al., 2006). The qualitative features of influenza A evolution are obtained when this is
combined with assumptions on strain space structure (Ferguson et al., 2003; Koelle et al.,
2006) or on immune response (Ferguson et al., 2003; Minayev and Ferguson, 2009a,b).
Apart from underlying SIR type dynamics with the same epidemiological parameters
for all strains, the only ingredient of the model that was kept unchanged in our study is the
hypothesis that, across the whole population, a single matching antibody confers immunity to
a challenging strain. Given that the agent-based simulations are free of the limitations of the
reduced deterministic model and validate its predictions, our results taken together strongly
suggest that the build up of antigenic diversity from a single founding strain by invasion
of mutants competing through cross-immunity is incompatible with that assumption, in the
framework of uniform SIR dynamics and unstructured strain space. This conclusion is in
agreement with the results of a study based purely on simulations in which strain diversity
is achieved by modifying that hypothesis (Parisi et al., 2013).
It is interesting to compare the results above with the fate of an antigenically identical
mutant that competes through increased infectiousness. In that case, strain substitution is
easily observed (results not shown). The model we develop here thus reveals a mechanism
acting at the population level that would favor a serologically monotypic virus evolving to-
wards increased infectiousness. For example, the virus of measles, a highly contagious disease,
exists as a single serotype, despite having in vitro mutation rates similar to other viruses such
as influenza that exhibit large antigenic diversity. The measles virus also seems to conform
to the hypothesis of immunity being conferred by a single matching anti-body. It has been
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shown that successful escape mutants may require changes in all the epitopes of its hemag-
glutinin protein targeted by human antibodies, and that this plays a role in keeping measles
serologically monotypic (Lech et al., 2013).
We speculate that the model developed here adequately describes the evolutionary epi-
demiology of a virus like measles, and that rapidly evolving, diverse pathogens such as in-
fluenza are associated with a weaker anti-body protection in some hosts.
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